Is TNYA research on Rallies investment advice?

No. Rallies provides research, data, and educational context for TNYA. It does not provide personalized investment advice.

TNYA (Tenaya Therapeutics, Inc. Common Stock) Stock Analysis - Financials

Tenaya Therapeutics, Inc. Common Stock (TNYA) is a publicly traded Healthcare sector company. As of September 4, 2026, TNYA trades at $0.70 with a market cap of $156.80M and a P/E ratio of -1.35. TNYA moved -0.67% today. Year to date, TNYA is -5.36%; over the trailing twelve months it is -43.93%. Its 52-week range spans $0.36 to $2.35. Analyst consensus is strong buy with an average price target of $10.80. Rallies surfaces TNYA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are TNYA's key financials?

TNYA financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. TNYA recently traded at $0.70. Market cap is $156.80M. P/E ratio is -1.35. Revenue is $1.33M.

TNYA Key Metrics

Key financial metrics for TNYA
Metric	Value
Price	$0.70
Market Cap	$156.80M
P/E Ratio	-1.35
EPS	$-0.52
Dividend Yield	0.00%
52-Week High	$2.35
52-Week Low	$0.36
Volume	1.50M
Avg Volume	0
Revenue (TTM)	$1.33M
Net Income	$-103.11M
Gross Margin	0.00%

TNYA Analyst Consensus

6 analysts cover TNYA: 0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $10.80.

Common questions about TNYA

What are TNYA's key financials?: TNYA financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. TNYA recently traded at $0.70. Market cap is $156.80M. P/E ratio is -1.35. Revenue is $1.33M.
Is TNYA research on Rallies investment advice?: No. Rallies provides research, data, and educational context for TNYA. It does not provide personalized investment advice.